Remove Atrial Fibrillation Remove BMI Remove Peripheral Arterial Disease
article thumbnail

Finerenone, chronic obstructive pulmonary disease, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS‐HF trial

European Journal of Heart Failure

The beneficial effects of finerenone in patients with heart failure (HF) and mildly reduced or preserved ejection fraction were consistent, regardless of a history of chronic obstructive pulmonary disease (COPD) status. BMI, body mass index; LVEF, left ventricular ejection fraction; NT-proBNP, N-terminal pro-B-type natriuretic peptide.

article thumbnail

Machine learning approach to identify phenotypes in patients with ischaemic heart failure with reduced ejection fraction

European Journal of Heart Failure

Then identified clusters are predicted and tested in the learning set to evaluate their association with outcomes. Finally, the reproducibility of the results of cluster analysis is tested in an external cohort (validation set). Aims Patients experiencing ischaemic heart failure with reduced ejection fraction (HFrEF) represent a diverse group.